Strides Pharma Reports Strong Q2 as Net Profit Surges 82%
Strides Pharma Science posted a sharp improvement in quarterly earnings, reporting that net profit rose 82% year-on-year to ₹131.5 crore in Q2 FY25, supported by robust U.S. business performance and margin expansion. Revenue grew 15% to ₹1,193 crore, driven by continued growth in regulated markets and improved product mix. The U.S. segment recorded 22% growth, supported by new launches and higher market share in key therapy areas, while the institutional business also contributed to revenue gains. The company reported an EBITDA margin of 20.3%, compared with 16.7% a year earlier, reflecting more favourable pricing and operational efficiencies. Management said the company remained focused on expanding its U.S. pipeline, strengthening its branded portfolio across emerging markets and scaling high-margin businesses. Strides reiterated confidence in sustaining double-digit growth, supported by steady launches and the monetisation of niche products in the quarters ahead.
You May Interested In
2026-08-22
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
After 20 Years of Negotiations, 90% of Tariffs to Be Cut! EU and Mercosur Sign Free Trade Agreement: Trade Barriers Ease, Transatlantic Cooperation Warms Up?
-
Is India’s “Luck” Finally Here? HPCL’s 10-Year LNG Deal Is a High-Stakes Bet on National Destiny
-
End of an Era: KDC/One to Close 150-Year-Old Somerset Cosmetics Factory as Production Shifts to Scotland
-
DKSH to Distribute Point Grey’s Baby and Personal Care Portfolio in Vietnam
-
When the Skin of Ships Gets More Expensive: A 30% Price Shock Is Quietly Rewriting the Cost Floor of Global Shipping
-
Sulfur Price Hits 7,633 CNY/Ton, Up Nearly Sixfold in a Year and a Half; Domestic Refining Giants Halt New Orders Due to Tight Supply
-
Kraton Announces Strategic Plan to Streamline Polymer Operations in Berre, France
-
UAE Breaks Ground on World’s First Gigascale Round-the-Clock Renewable Energy Project, Setting a New Global Standard For Clean Energy
-
Minoxidil Safety Under Global Review as Infant Exposure Risks Surface
-
Substandard Drug Findings Expose Deep Structural Gaps in Medicine Quality Control
Recommend Reading
-
![Spain’s Data-Protection Confusion Hits Pesticide Competitiveness]()
Spain’s Data-Protection Confusion Hits Pesticide Competitiveness
-
![Spain’s Data-Protection Confusion Hits Pesticide Competitiveness]()
Spain’s Data-Protection Confusion Hits Pesticide Competitiveness
-
![New York Targets Additives and GRAS Disclosure]()
New York Targets Additives and GRAS Disclosure
-
![India Raises Cancer Drug Price Caps by 50%]()
India Raises Cancer Drug Price Caps by 50%
-
![Pfizer Warns Germany Over Drug-Pricing Policy]()
Pfizer Warns Germany Over Drug-Pricing Policy
-
![China's Soda Ash Market Remains Stable]()
China's Soda Ash Market Remains Stable
-
![This week, the market price of propylene oxide in China has slightly increased (9.1-9.5)]()
This week, the market price of propylene oxide in China has slightly increased (9.1-9.5)
-
![Recent Formic Acid Market Shows]()
Recent Formic Acid Market Shows "Decreased Volume, Stable Prices" Trend in China
-
![Since November, the phenol market in China has seen more declines than increases]()
Since November, the phenol market in China has seen more declines than increases
-
![Downstream Fluctuations: Butadiene Prices Oscillate Within a Range]()
Downstream Fluctuations: Butadiene Prices Oscillate Within a Range
